Haleon plc

- There is no mention of any current or planned new fundraising through debt or equity in the provided document. - The company discusses significant cost-saving measures and supply chain productivity improvements, generating $175 million to $200 million in gross savings, which provide flexibility for investment without external fundraising. - There is a focus on investing internally through improved margin and efficiency to support growth and innovation. - No direct references were made to issuing new equity or taking on new debt during the Fiscal Year 2025 results call or in the Q&A.

- The company is focusing on investing at a healthy level of 20.5% of sales, emphasizing sustainable growth. - Increased A&P (advertising and promotion) spend by 7.5% and R&D by 7.7% to support brand growth, especially in Oral Health and emerging markets. - Investments are directed towards digital media (60% of working media) to balance legacy and digital marketing. - Significant investment in supply chain productivity programs, focusing on reducing complexity (e.g., packaging harmonization) and operational efficiency (e.g., reducing formulations to increase capacity). - Increased the sales force and field force engagement, including bringing sales forces in-house in countries like India to expand reach. - Future supply chain productivity improvements are expected at 50 to 80 basis points annually. - Strategic investments include expanding presence in emerging markets (India, China) and enhancing e-commerce capabilities (e.g., Douyin in China).

- Organic sales growth guidance for 2026 is 3% to 5%, signaling some sequential acceleration from 3% in 2025. - Medium-term ambition remains 4% to 6% growth, supported by expected stronger performance in North America and continued strength in emerging markets. - Volume growth is a focus, with a target price-volume mix split around 60-40 in favor of volume, especially from Asia Pacific (80% volume-driven growth). - Key drivers include shelf resets, distribution gains, and commercial activations planned in 2026, particularly in the U.S. market. - Innovation and increased investment in Advertising & Promotion (A&P) and R&D support growth expectations. - Challenges identified include a softer cold and flu season impacting 2025, but medium-term fundamentals and strategies (premiumization, low-income consumer growth, and category expansion) remain intact. - Supply chain and productivity improvements provide margin flexibility to reinvest for growth.

- Haleon expects to return to growth in 2026, with the U.S. market improving based on inventory normalization and shelf reset initiatives. - Medium-term organic sales growth guidance remains at 4% to 6%, supported by continued strength in emerging markets (India, China) and operational improvements. - Operating margin improvements driven by supply chain productivity (220 basis points gross margin improvement in 2025) enable ongoing investment in growth (A&P, R&D). - Haleon targets high single-digit constant currency operating growth while maintaining investments in marketing and innovation. - Efficiency gains and new organizational structure (Chief Growth Officer role) aim to accelerate growth execution and volume improvements. - Volume growth focus includes reducing destocking impacts and leveraging digital/digital media investments (60% of working media). - Short-term 2026 guidance for organic sales growth of 3% to 5%, reflecting near-term market uncertainties, with gradual sequential acceleration expected.

The provided pages (3 to 10) of the document do not mention or discuss "Current/ Expected Orderbook/ Pending Orders." The transcript focuses primarily on financial results, market strategy, supply chain productivity, advertising and promotional spend, U.S. market dynamics, category performance, and organizational changes at Haleon. There is no explicit information related to orderbook status or pending orders. If you have another section or document where this information might be available, please share it, and I will be glad to help.